SEVERE COVID-19

Clinical trials for SEVERE COVID-19 explained in plain language.

Never miss a new study

Get alerted when new SEVERE COVID-19 trials appear

Sign up with your email to follow new studies for SEVERE COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

Desperate patients get early access to promising drug

Disease control AVAILABLE

This program provides early access to the drug ruxolitinib for people with serious or life-threatening conditions like certain blood cancers, severe COVID-19, or graft-versus-host disease. It is for patients who have no other treatment options and cannot join a clinical trial. Th…

Matched conditions: SEVERE COVID-19

Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC

SEVERE COVID-19

Get alerted when new SEVERE COVID-19 trials appear

Desperate patients get early access to promising drug